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Summary: The effects of cerebral ischemiaireperfusion on phosphorylation of microtubule-associated tau proteins were assessed in a canine model of cardiac arrest. As tau proteins are phosphorylated by kinases involved in different transduction signal pathways, their phosphorylation state is an excellent marker of neuronal homeostasis and microtubule dynamics. Canine brain tau proteins were characterized by immunoblot ting using phosphorylation-dependent antibodies and antisera raised against different amino-and carboxy-terminal tau se quences. The present study reports a complete dephosphoryla tion of tau proteins during ischemia, which is shown by a higher electrophoretic mobility and the almost (if not total) disappcarance of phosphorylation-dependent monoclonal anti body labeling. After 2-hour restoration of spontaneous circula-Tau proteins belong to the microtubule-associated pro tein family. They are found primarily in neurons. In the human adult brain, alternative splicing of three exons (exons 2, 3, and 10) of a single gene generates six tau isoforms (Goedert et al., 1989a,b) , which range from 352 to 44 1 amino acids with an apparent molecular mass from 45 to 74 kDa, when separated by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (SDS-PAGE). From a structural point of view, tau amino-terminal domain cOlTesponds to the projection domain and may interact with cytoskeletal elements and tion, a decrease in the electrophoretic mobility was observed, and after 24 hours of reperfusion, a full restoration of the phos phorylation was visualized using phosphorylation-dependent monoclonal antibodies directed against Ser/Thr-Pro sites. How ever, one particular phosphorylation site involved in tau bind ing to microtubules, located on Ser 262/356 , was never fully sig nificantly rephosphorylated, suggesting that microtubule me tabolism was still affected after 24 hours of reperfusion. Thus, the sequential and differential recovery of tau phosphorylation after ischemia followed by reperfusion is a useful marker with which to monitor neuronal integrity after brain ischemia. Key Words: Alzheimcr's disease-Animal model-Brain isch emia-Microtubule-associated tau proteins-Phosphorylation. mitochondria (Hirokawa et al., 1988; Rendeon et ai., 1990) . Tau proteins bind to microtubules through repeti tive regions in their carboxy-terminal part (Lee et ai., 1989) . This binding is regulated by the degree of Ser/Thr phosphorylation of tau proteins. One of the critical sites of phosphorylation in tau binding to microtubules is Ser 262 , a non-SerlThr-Pro site (numbering according to the longest human tau isoform in brain, 441 amino acids) (Biernat et aI., 1993; Schneider et ai., 1999) . A number of phosphorylation-dependent monoclonal antibodies have been developed against many different tau phos phorylation sites (for review, see Buee and Delacourte, 1999) . The different states of tau phosphorylation re sult from kinase and phosphatase activities. Phosphory lation sites are also found on native tau from biopsy derived samples, but they are rapidly dephosphorylated after death, due to postmortem phosphatase activity (Matsuo et ai., 1994) . By SDS-PAGE, this tau dephos phorylation is characterized by a decrease in apparent molecular mass (Baudier and Cole, 1987; Matsuo et aI., 1994) .
Prolonged cerebral ischemia, as occurs in focal isch emia models, results in disruption of the neuronal cyto skeleton. This can occur by proteolysis of microtubules and other components; however, tau protein immunore activity is relatively unaffected (Pettigrew et a!., 1996) . Cytoskeletal disruption can also occur through the ef fects of ischemia on protein phosphorylation that control cytoskeletal assembly and stability (Dewar et a!., 1994; Pettigrew et a!., 1996) . Recent studies have indicated that tau dephosphorylation is an early event that occurs dur ing ischemia but does not persist during reperfusion re gardless of the neurological outcome (Burkhart et a!., 1998; Shackelford and Yeh, 1998) . Furthermore, tau pro teins are normally highly phosphorylated, and all phos phorylation sites may not be similarly affected by isch emia as they involve activity of different kinasesl phosphatases. In fact, phosphorylation of particular sites on tau proteins may reflect microtubule dynamics and activation of different transduction signals. In the present study, we have investigated more especially the rephos phorylation period of tau protein after the ischemic insult followed by a short time of reperfusion in a clinically relevant canine model of cardiac arrest and resuscitation (Rosenthal et a!., 1992) . We observed a rapid dephos phorylation of tau during ischemia that was more or less recovered after 24-hour restoration of spontaneous cir culation (ROSC) according to the different tau phosphor ylation sites.
MATERIALS AND METHODS

Animal experiments
All animal experiments were conducted in accordance with guidelines established by the Institutional Animal Care and Use Committee of the George Washington University Medical Cen ter. The canine cardiac atTest and resuscitation model of global brain ischemia and reperfusion was performed essentially as described by Rosenthal et a!. (1992) and utilized chloralose anesthetized female adult beagles. Four animal groups were used in this study: sham-operated, nonischemic control animals (n = 4); animals that underwent 10 minutes of electrically induced ventricular fibrillation cardiac arrest without ROSC (n = 4); and animals subjected to IO minutes of cardiac arrest, resuscitation, and either 2 hours of ROSC (n = 3) or 24 hours of ROSC (n = 4). Previous studies have demonstrated a mod erate to severe degree of neurologic impairment in these ani mals subjected to IO-minute global cerebral ischemia and 24hour reperfusion (Rosenthal et a!., 1992; Liu et aI., 1998) , based on a standardized neurologic deficit scoring system similar to that used by Bircher and Safar (1985) and others (Zwemer et a!., 1994) . These animals typically exhibit normal respiration but show marked alterations of their levels of consciousness and are incapable of standing or drinking. We and others have demonstrated substantial delayed cell death in the hippocampus and cortex (for example, 30% in cortical layer V pyramidal cells) following 24 to 96 hours of reperfusion without histo logic evidence of acute death after only 2 hours of reperfusion (Bogaert et a!., 1996; Radovsky et aI., 1995) .
At the end of the appropriate experimental period, a crani otomy was performed on anesthetized animals, and samples J Cereb Blood Flow Metab, Vol. 20, No.3, 2000 from the frontal cerebral cortex were immersed in liquid nitro gen within 5 seconds after excision and then stored at -80°e. Homogenates were generated using 100 mg of frozen tissue/ mL of Laemmli sample buffer and boiled at 100°C for 10 minutes.
Cell culture and transfection COS-7 cells were grown in 25-cm 2 t1asks in Dulbecco's modified Eagle's medium (Life Technologies, Cergy Pontoise, France) with 10% fetal calf serum (Boehringer Mannheim) in a 5% CO 2 incubator at 37°C. The eDNA of the six human tau isoforms was cloned in pSG5 vector (Stratagene; a kind gift of Dr. M. Goedert, Cambridge, U.K.). Tau cDNAs were tran siently transfected in COS cells using the diethylaminoethyl dextran method. Forty-two hours after transfection, cells were treated or not by okadaic acid (OA; Sigma, St. Louis, MO, U.S.A.), an inhibitor of protein phosphatases 1 and 2A, for 6 hours, as previously described (Mailliot et a!., 1998; Sautiere et a!., 1994) . Cells were harvested in ethylenediaminetetraacetate solution at 4°C and centrifuged. Cell pellets were homogenized in Laemmli sample buffer (Laemmli, 1970) and boiled for 10 minutes.
Antibodies
Antibodies used in the present study are summarized in Fig,  I , and numbering of the epitopes is given according to the longest human tau isoform. Phosphorylation-dependent mono clonal antibodies included 12E8 recognizing phosphorylated Ser 262 and to a lesser extent phosphorylated Ser 356 (Seubert et a!., 1995) , AD2 directed against phosphorylated Ser 396 to Ser 404 (Buee-Scherrer et aI., 1996) , AT 180 labeling phosphorylated Thr 23I , AT270 recognizing phosphorylated Thr 181 , AT8 di rected against phosphorylated Ser 202 /Thr 20s (Goedert et a!., 1994 , and Tau-I, which binds amino acids 189 to 207 only when they are dephosphorylated (Szendrei et aI., 1993) .
With the exception of 12E8, all other phosphorylation dependent monoclonal antibodies (AD2, AT8, AT180, and AT270) recognize Ser/Thr-Pro sites. Well characterized poly clonal antibodies against different regions of tau proteins were also used and consisted of E2, E3, and EIO directed against sequences encoded by exons 2, 3, and 10, respectively (Mailliot et aI., 1998; Sergeant et a!., 1997) . Finally, MI9G is a well characterized antiserum, directed against the first 19 amino acids of the tau sequence encoded by exon I (Buee-Scherrer et a!., 1996; Sautiere et a!., 1994). All polyclonal antibodies rec ognize their epitope independently of the tau phosphorylation state.
Immunoblotting
Electrophoresis and immunoblotting were performed as pre viously described (Buee-Scherrer et aI., 1996; Mailliot et a!., 1998) . In brief, samples were loaded onto SDS-PAGE gels. Two vertical electrophoresis systems were used: a minigel sys tem from Pharmacia Biotech (using 10% SDS-PAGE) and Bio Rad Protein II (10 to 20% slab gel). After transfer to nitrocel lulose (Amersham), membranes were blocked with 5% skim milk and incubated with the primary antibody overnight at 4°C. Horseradish peroxidase-conjugated antibody was used as sec ondary antibody, and reaction product was detected using the Amersham ECL Western blotting system.
Quantitative analysis
All quantitative analyses were performed as described by 
RESULTS
Effect of ischemia/reperfusion on canine brain tau proteins
By immunoblotting using the polyclonal antibodies MI9G, E2, E3, and ElO, we investigated the nature of tau isoforms in our canine model of global cerebral isch emialreperfusion. No high molecular mass tau variants were detected in normal canine brain. Two major tau variants were labeled at 72 to 74 kDa with antibodies E2, E3, and ElO (data not shown). The same bands as well as other lower molecular mass variants between 68 and 74 kDa were visualized with Ml90 (Fig. 2, lane 2) and co-migrated with the longest human tau isoform (2+3+ 10+) transfected in COS cells treated with OA (Fig. 2, lane 1) . Moreover, these 72-to 74-kDa canine variants co-migrated with the 72-to 74-kDa variant found in human brain (Sergeant et aI., 1997) . These data suggested that canine cerebral tau variants were phos phorylated in normal conditions to the same extent as human brain tau proteins.
After lO-minute global cerebral ischemia, a shift in the electrophoretic mobility of these variants occurred and the labeling was visualized around 68 kDa (Fig. 2, lane  3) , as observed in transfected non-OA-treated COS cells (Fig. 2, lane 4) , indicating that dephosphoryla tion had occurred. Whatever the conditions, tau variants were detected by all tau polyclonal antibodies (M 190, E2, E3, and ElO) and gave the same electrophoretic pro files.
Effect of ischemia/reperfusion on cerebral cortex tau phosphorylation
To investigate tau protein phosphorylation state during the ischemialreperfusion protocol, different phosphory lation-dependent monoclonal antibodies (12E8, AD2, A T8, AT 180, A T270, and Tau-I) were used. In control samples, all phosphorylation-dependent monoclonal an tibodies, with the exception of Tau-l antibody, labeled two broad bands around 74 kDa (as shown for AD2 antibody in Fig. 3A, lane 2) . Transfected human tau 2+3+ 10+ from OA-treated COS cells showed the same tau immunoreactivity (Fig. 3A, lane 1) . After ischemia alone, a loss of immunoreactivity was observed. AD2 and 12E8 did not label ischemic samples anymore (Fig.  3A, lane 3) , whereas AT270 showed a much weaker staining at 68 kDa. The human tau 2+3+ I O+-transfected non-OA-treated cells were not labeled anymore by AD2 antibody (Fig. 3, lane 4) . In the case of ischemia fol lowed by 2-hour ROSC, phosphorylation-dependent tau immunoreactivity was much more intense than that ob served with samples obtained after ischemia in the ab sence of reperfusion. In particular, a 72-kDa band was very evident (Fig. 3A, lane 5) . After 24 hours of ROSC, this band was still apparent, but the 74 kDa was much more intense [especially for AD2 (Fig. 3A, lane 6) , AT8, and AT270j. Conversely, Tau-l antibody strongly la beled ischemic samples around 68 kDa, whereas in nor-
Tau isoform in the canine model of brain ischemia/ reperfusion. Immunoblotting was performed using polyclonal an tibody M19G. This phosphorylation-independent antibody la beled different tau variants between 68 and 74 kDa (arrowheads on left). High molecular mass tau variants at 72 to 74 kDa were detected in COS cells transfected with 2+3+ 10+ cDNA (hT40) and okadaic acid-treated cells (lane 1) as well as in control dog cells (lane 2). Lower molecular mass tau variants around 68 kDa were found in dog brains after ischemia (lane 3) and in trans fected non-okadaic acid-treated COS cells (lane 4). A similar electrophoretic pattern was obtained with all other polyclonal an tibodies. A major isoform at 72 to 74 kDa is labeled in the control canine cerebral cortex, and its electrophoretic mobility increased after 10 minutes of ischemia. mal and 24-hour ROSC conditions, Tau-I poorly labeled the 72-kDa tau variant. Tau-l did not label transfected human tau 2+3+ 10+ from OA-treated cells (Fig. 3B, lane  1) , but it labeled transfected non-OA-treated cells (Fig.  3B, lane 4) .
Quantitative analysis of tau immunoreactivity
Quantitative analysis of tau phosphorylation was per formed by immunobJotting using monoclonal antibodies AD2, ATS, ATlSO, AT270, 12ES, and Tau-I (Fig. 4) . All values were expressed after correction of the tau amount estimated by ElO immunoreactivity. This cor rection allowed for elimination of possible variations among samples due to differences in tau content. Fur thermore, it should be noted that no increase in the amount of low molecular mass tau products consistent with proteolysis was observed in any conditions.
In control dogs, high levels of AD2 immunoreactivity were observed. In ischemic conditions, this immunore-J Cereb Blood Flow Metah. Vol. 20, No. 3. 2000 activity was significantly reduced (Table 1; Mann Whitney U test, P < 0.05) and actually appeared to be completely eliminated. After 2 hours of ROSC, phos phorylation at the AD2 epitope was restored and there was no significant difference in immunoreactivity com pared with samples from control dogs. After 24 hours of ROSC, levels of AD2 immunoreactivity were compa rable with those in control conditions. Similar results were obtained using the A TS, A TlSO, and AT270 anti bodies; however, -25% of control immunoreactivity was still apparent after 10 minutes of cerebral ischemia, and the restoration of the initial level of phosphorylation was more progressive for these antibodies. The pattern of 12ES immunoreactivity was similar to that of AD2 in the sense that there was a complete loss of signal after isch emia alone. However, unlike the immunoreactivity with either AD2 or A T270, the 12ES immunoreactivity con tinued to be significantly lower than that of control tissue at both 2 and 24 hours of reperfusion (Table 1 ; P < 0.05). Conversely, Tau-l immunoreactivity was lower in con trol samples, whereas it increased during ischemia and dwindled again after 2 and 24 hours of ROSC (Table I) .
DISCUSSION
In the present study, we demonstrated that rapid and extensive tau dephosphorylation occurs in the frontal cortex in a clinically relevant cardiac arrest model of global cerebral ischemia. These results corroborate those of Shackelford and Yeh (199S) on rapid tau dephos phorylation during transient rat cerebral ischemia. The use of a large variety of phosphorylation-dependent monoclonal antibodies allowed us to easily study tau phosphorylation at different well defined sites, demon strating that it was site specific. Furthermore, tau variants in canine brain are in fewer number than in rodent brain where numerous bands are labeled with AD2 and Tau-I antibodies (Shackelford and Nelson, 1996; Shackelford and Yeh, 1995) . The most sensitive epitope to dephos phorylation was that recognized by AD2, which includes residues Ser 396 and Ser 404 . After resuscitation and cere bral reperfusion, most phosphorylation sites, including those of ATSffau-J, AT 1S0, and AT270, were com pletely rephosphorylated. However, the sites recognized by 12ES, located primarily on Ser 262 and to a lesser extent on Ser 356 , were not fully rephosphorylated, even after 24 hours of reperfusion. Our study therefore dem onstrates that all the phosphorylation sites on tau proteins do not react to the same extent to the ischemic injury: There is a sequential and differential recovery of tau phosphorylation after ischemia and reperfusion accord ing to the different tau phosphorylation sites we consider. This moderates the conclusions of all previous studies on tau phosphorylation during and after ischemia, which explained that tau proteins were rapidly dephosphory- I c lated during ischemia and then recovered their initial phosphorylation state after reperfusion, regardless of the neurological outcome. But all of these studies focused only on a few tau phosphorylated residues, mainly those recognized by AD2 and Tau-l antibodies.
Tau dephosphorylation during ischemia
If we consider tau dephosphorylation during ischemia, it may result from specific activation of phosphatases after different ischemia-related phenomena including ap optosis and cytoskeletal alterations. Recently, apoptosis has drawn attention in ischemic neuronal death. Bcl-2 family proteins, DNA fragmentation, and release of caspase-9 from mitochondria have been involved in isch emia (Krajewski et aI., 1999; MacManus et a!., 1999; Matsushita et aI., 1998) . It should be noted that activation of protein phosphatase 2A and dephosphorylation of tau protein were reported as early phenomena of the execu tion phase of apoptosis (Mills et aI., 1998) . Finally, one
of the most striking alterations that occurs during isch emia and reperfusion is an increase in intracellular levels and redistribution of calcium. This leads to an overacti vation of glutamate receptors and has deleterious effects on cytoskeleton integrity by modulating calcium dependent kinases/phosphatases and proteases; this gen erates proteolysis of microtubules and dysregulation of the tau kinase/phosphatase balance. Moreover, elevated intracellular calcium may compromise mitochondrial function, leading to tau dephosphorylation at Tau-1 site through calcineurin activation (Norman and Johnson, 1994) . As mitochondria may bind to microtubules through tau interactions (Rendeon et aI., 1990) , tau phos phorylation is likely to be modified after changes in ei ther microtubule dynamics or mitochondria metabolism. Conversely, altered microtubule structure-impaired fast axonal transport of mitochondria is believed to play a role in the delayed mitochondrial degeneration observed after cerebral ischemia (Abe et aI., 1995) . Thus, a num-C. MAILLIOT ET AL. ber of ischemia-related phenomena could explain tau de phosphorylation, which is a characteristic feature re ported in a number of studies on ischemia.
Sequential and differential restoration of tau phosphorylation
Among the Ser-Pro and Thr-Pro sites analyzed in the present study, the AD2 site was completely dephos phorylated during ischemia. After 2-hour ROSC, a full restoration of phosphorylation was already observed. Among tau phosphorylation sites, AD2 is a Ser/Thr-Pro one. It is thus interesting to note that phosphorylation of tau proteins on Ser/Pro or ThrlPro residues does not sig nificantly modify tau-microtubule interactions (Schneider et aI., 1999) . This could explain why an al most complete recovery of these sites is obtained after 24-hour ROSC, because they are less implicated in the restoration of the microtubule network integrity and thus of a normal intracellular trafficking than the non Ser Thr/Pro sites Ser 262/356 . Finally, one of the most striking findings of our pre sent study was the incomplete restoration of tau phos phorylation on Ser 2621356 residues even after 24-hour ROSC. Interestingly, Ser 262/356 are located within the microtubule binding domains of tau. Moreover, Ser 262 phosphorylation alone has been shown to dramatically reduce tau affinity for microtubules (Biernat et aI., 1993; Schneider et aI., 1999) . Nevertheless, this particular site is insufficient to eliminate tau binding to microtubules (Seubert et aI., 1995) . After ischemia, microtubule me tabolism and dynamics are severely affected (Minger et aI., 1998; Pettigrew et aI., 1996) . Thus, during reperfu sion, tubulin polymerization into microtubules is likely to be a major process necessary for restoration of normal axonal transport. The persistent abnormally low level of Ser 262 phosphorylation we have observed may result in a prolonged shift in the tubulin-microtubule equilibrium toward the polymerized state. On the other hand, the J Cereb Blood Flow Metab, Vol. 20, No. 3, 2000 mechanisms responsible for changes in tau phosphoryla tion and differential rephosphorylation during cerebral ischemia and reperfusion likely involve changes in the activities of specific phosphatases and kinases. Some of the kinases responsible for Ser 262/356 phosphorylation have already been identified and include cyclic AMP dependent protein kinase, calcium/calmodulin-dependent protein kinase II, phosphorylase K, and mitogen activated protein kinase (Drewes et aI., 1997; Ilienberger et aI., 1998; Litersky et aI., 1996; Paudel, 1997) . In a reversible model of spinal cord ischemia in rabbits, tau proteins have been found to be partially dephosphory lated in response to ischemia with a time course that closely correlates with the period necessary for installa tion of permanent paraplegia. Moreover, loss of calcium! calmodulin-dependent protein kinase II activity was shown to be an early marker of ischemia in the same model (Shackelford and Nelson, 1996) . Thus, during the reperfusion period in our model, the inhibition of cal cium/calmodulin-dependent protein kinase II may ex plain the low degree of Ser 262 phosphorylation that fa cilitates tau binding to microtubules.
In conclusion, the differential phosphorylation of tau proteins is a physiological neuronal marker that may contribute to monitor transduction signals (restoration of full phosphorylation on Ser/Thr-Pro sites). Moreover, tau phosphorylation is an indicator of neuronal metabolism as some non-Ser/Thr-Pro phosphorylation sites on tau proteins such as Ser 262 /Ser 356 reflect microtubule dy namics. During reperfusion, tau proteins are not fully rephosphorylated at Ser 262 /Ser 356 , which may indicate a chronic alteration of microtubule dynamics and therefore abnormal axonal transport. A defect in axonal transport of mitochondria and other cell constituents might con tribute to delayed neuronal damage observed after reper fusion. Finally, as tau isoforms are differentially ex pressed in subpopulations of neurons in human brain, tau proteins are of particular interest to define subpopula tions of neurons selectively vulnerable to ischemia.
